09:35 AM EST, 02/25/2025 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Tuesday it has named Lindsay Androski as chief executive, effective immediately.

The company said Androski succeeds interim CEO and President Michael J. McElhaugh, and will join the company's board.

Androski is a special counsel at Genevant, Arbutus said.

All existing board members have stepped down from their roles, Arbutus said, adding that four new members, in addition to Androski, have been added.

Price: 3.55, Change: +0.21, Percent Change: +6.29